ADAGIO THERAPEUTICS INC's ticker is and the CUSIP is 00534A102. A total of 75 filers reported holding ADAGIO THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.49 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,449,233 | +61.9% | 1,440,725 | 0.0% | 0.12% | +101.7% |
| Q2 2023 | $1,512,761 | -12.5% | 1,440,725 | 0.0% | 0.06% | -22.7% |
| Q1 2023 | $1,728,870 | -20.0% | 1,440,725 | 0.0% | 0.08% | -14.8% |
| Q4 2022 | $2,161,088 | -64.1% | 1,440,725 | -25.0% | 0.09% | -62.2% |
| Q3 2022 | $6,013,000 | -4.6% | 1,920,960 | 0.0% | 0.23% | -3.3% |
| Q2 2022 | $6,301,000 | -28.1% | 1,920,960 | 0.0% | 0.24% | -11.7% |
| Q1 2022 | $8,760,000 | -37.2% | 1,920,960 | 0.0% | 0.27% | -13.9% |
| Q4 2021 | $13,946,000 | -89.8% | 1,920,960 | -40.8% | 0.32% | -86.7% |
| Q3 2021 | $137,152,000 | – | 3,246,960 | – | 2.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 9,248,250 | $15,722,025 | 18.03% |
| Alphabet Inc. | 5,680,785 | $9,657,334 | 0.62% |
| 683 Capital Management, LLC | 4,000,000 | $6,800,000 | 0.53% |
| Bain Capital Life Sciences Investors, LLC | 1,937,207 | $3,293,252 | 0.37% |
| Acuitas Investments, LLC | 208,579 | $354,584 | 0.21% |
| MAVERICK CAPITAL LTD | 5,270,290 | $8,959,493 | 0.20% |
| Orbimed Advisors | 5,270,400 | $8,959,680 | 0.19% |
| Slate Path Capital LP | 3,735,000 | $6,349,500 | 0.18% |
| Redmile Group, LLC | 1,440,725 | $2,449,233 | 0.12% |
| TANG CAPITAL MANAGEMENT LLC | 366,536 | $623,111 | 0.09% |